Boston Trust Walden’s Lam Research LRCX Stock Holding History
Bought
Maintained
Sold
Other funds holding LRCX
Boston Trust Walden's LRCX Position: Q3 2026 in Review
Boston Trust Walden reduced its Lam Research (LRCX) stake by 24% in Q3 2026, selling an estimated $4.99M and leaving 50,451 shares worth $16.6M. The position accounts for 0.13% of the portfolio, ranked #181.
Boston Trust Walden first reported a position in LRCX in Q2 2024 and has held it in 6 quarters since. The position peaked at $28.8M in Q2 2026. 2,967 funds tracked by Wall St. Rank hold LRCX as of Q3 2026.
- Boston Trust Walden held 50,451 shares of Lam Research worth $16.6M as of Q3 2026.
- Boston Trust Walden sold 15,973 Lam Research shares in Q3 2026, an estimated $4.99M.
- Lam Research made up 0.13% of Boston Trust Walden's portfolio in Q3 2026, its #181 holding.
- Boston Trust Walden first reported a position in Lam Research in Q2 2024 and has held it in 6 quarters since.
- Boston Trust Walden's Lam Research position peaked at $28.8M in Q2 2026.
- 2,967 funds tracked by Wall St. Rank held Lam Research as of Q3 2026.
Based on Boston Trust Walden's 13F filing for Q3 2026, filed 30 Oct 2026.